Atezolizumab Monoclonal Antibody from China
Atezolizumab humanized IgG1 blocking PD-L1 for bladder cancer. Bulk unmixed HTS 3002.13.0010.
Duty Rate — China → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• PD-L1 specificity docs
• Trial kit exclusions